GlassScriptPhysician profile
Mary Caroline Stancukas
NPI 1356757934
$2,446.87
in general payments reported to CMS, 2019-2025
25 companies · $893 in 2025
The $893 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $655 · 2020: $30.12 · 2021: $88.12 · 2022: $118 · 2023: $22.09 · 2024: $640 · 2025: $893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,555.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $654.62 | 2024-2025 | Qutenza |
| Smith+Nephew, INC. | $225.58 | 2019-2025 | Collagenase Santyl, Versajet, Stravix |
| Wright Medical Technology, INC. | $208.91 | 2019 | |
| Stryker Corporation | $188.52 | 2019-2023 | Ortholoc 2 Lapifuse |
| Amgen INC. | $179.61 | 2024-2025 | Krystexxa |
| Kerecis Limited | $142.30 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Horizon Therapeutics Plc | $127.97 | 2019-2020 | |
| Organogenesis INC. | $115.58 | 2025 | Via Matrix, Apligraf |
| Novastep INC. | $104.17 | 2022 | |
| Innovation Technologies INC | $72.48 | 2024 | Irrisept |
| Paratek Pharmaceuticals, INC. | $55.66 | 2024-2025 | Nuzyra |
| Zimmer Biomet Holdings, INC. | $37.63 | 2021 | |
| Acumed LLC | $37.56 | 2024 | Acumed |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $34.47 | 2019 | |
| Convatec INC. | $31.38 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $29.00 | 2024 | Tymlos |
| Misonix INC | $25.97 | 2019 | |
| Polynovo North America LLC | $24.92 | 2024 | Novosorb Btm |
| Melinta Therapeutics, LLC | $24.86 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $24.21 | 2025 | |
| Lifenet Health | $23.91 | 2025 | Theragenesis Wound Matrix |
| Depuy Synthes Sales INC. | $22.91 | 2024 | |
| Musculoskeletal Transplant Foundation INC. | $21.53 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $18.12 | 2025 | Iovera |
| Orthofix Medical, INC. | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Stancukas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.